Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)

Thumbnail
Fulltext:
25172.PDF
Size:
1.428Mb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
1997
Author(s)
Lowenberg, B.
Suciu, S.
Archimbaud, E.
Ossenkoppele, G.J.
Verhoef, G.E.G.
Vellenga, E.
Wijermans, P.
Berneman, Z.
Dekker, A.W.
Stryckmans, P.
Schouten, H.C.
Jehn, U.
Muus, P.
Sonneveld, P.
Dardenne, M.
Zittoun, R.
Source
Blood, 90, 8, (1997), pp. 2952-2961
ISSN
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/25172   https://hdl.handle.net/2066/25172
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.